Back

Galectin-3 inhibition prevents cardiac dysfunction in murine experimental type 3 cardio-renal syndrome

2 May 2017 (08:00 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 4 - Basic science: Cancer and cytokines Cardio-renal syndrome HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Ms Mathilde Prud'homme

Inserm UMR 702, Paris (France)

14 More presentations in this session

Presentation thumbnail
Doctor D. Cappetta (Naples, IT)
Presentation thumbnail
Professor E. Morel (Orsay, FR)
Abstract
Presentation thumbnail
Doctor V. Sala (Turin, IT)
Abstract
Presentation thumbnail
Ms M. Genest (Paris, FR)
Abstract
Presentation thumbnail
Doctor S. Volkova (Tyumen, RU)

Access the full session

Session thumbnail
Poster Session 4 - Basic science: Cancer and cytokines

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

2 May 2017 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Galectin 3 : possible tool for early detection of LV diastolic dysfunction in asymptomatic survivors of childhood, adolescent and young adult cancer
20 June 2025
thumbnail
Congress Session
Redefining mineralocorticoid receptor antagonism in cardio-kidney-metabolic syndrome: from evidence to innovation
18 May 2025
thumbnail
Congress Presentation
Fibroblast-specific SOCS3 deficient mice exhibits decreased myocardial fibrosis and increased cardiomyocyte survival after acute myocardial infarction
26 August 2023
thumbnail
Congress Presentation
Role of NLRP3 inflammasome in cardiac damage in the setting of an acute cardiorenal syndrome
12 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources